Cambridge Raman Imaging is developing a microscope which uses graphene to modulate ultra-short pulses of light to diagnose cancer tumours.
Cambridge Raman Imaging has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in May 2022.
Cambridge Raman Imaging's investors include Frontier IP Group plc, Graphene Flagship.
Cambridge Raman Imaging is headquartered in Petersfield, United Kingdom.
Cambridge Raman Imaging is developing a microscope which uses graphene to modulate ultra-short pulses of light to diagnose cancer tumours.
Cambridge Raman Imaging is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cambridge Raman Imaging — Funding & Investors." VCBacked, May 24, 2022, https://www.vcbacked.co/company/cambridge-raman-imaging. Accessed September 30, 2026.
VCBacked. (2022). Cambridge Raman Imaging — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cambridge-raman-imaging
{{cite web |title=Cambridge Raman Imaging — Funding & Investors |url=https://www.vcbacked.co/company/cambridge-raman-imaging |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated